NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)
Clinical trial NCT03804866 · COMPLETED
Trial details
- NCT number
- NCT03804866
- Sponsor
- AGC Biologics S.p.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2016-12-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.